As Lionel Messi continues to add to his legendary career during the 2026 FIFA World Cup, renewed interest in the Argentina captain has also put the spotlight on a little-known chapter of his childhood: his battle with growth hormone deficiency (GHD), the condition that threatened to end his football ambitions before they truly began.
The football champion stands at approximately 5 feet 7 inches (1.70 meters), with his stature having been frequently discussed throughout his career, but his height is rooted in a medical condition rather than genetics alone. He was diagnosed with growth hormone deficiency at age 11 and required years of hormone therapy to support his growth, a treatment that his family initially struggled to afford before FC Barcelona agreed to help cover the costs after signing him to its famed La Masia academy.
The Finer Details of His Struggle
Messi was already recognized as one of Argentina's brightest young football prospects when doctors discovered his pituitary gland was not producing enough growth hormone, a protein essential for normal growth during childhood.
Without treatment, his physical development was expected to lag significantly behind that of his peers, potentially limiting his chances of competing at the highest levels of professional football. According to reports, the cost of daily growth hormone injections was beyond what his family could consistently afford, creating uncertainty about whether he could continue treatment.
Barcelona ultimately offered Messi an opportunity that changed the trajectory of his life. The Spanish club agreed to sign the young forward and support his medical treatment while he developed in its youth academy. Over the following years, Messi received recombinant human growth hormone therapy, allowing him to achieve more typical growth while continuing to refine the extraordinary technical skills that would later make him one of football's greatest players.
While hormone therapy helped address his growth disorder, Messi's success was ultimately driven by his talent, discipline, and years of development rather than treatment alone.
A Better Understanding of Growth Hormone Deficiency
Growth hormone deficiency (GHD) occurs when the pituitary gland, a small gland located at the base of the brain, does not produce enough growth hormone. The hormone plays a critical role in stimulating bone and muscle growth, regulating metabolism, and helping children reach their expected adult height.
According to the Cleveland Clinic and Johns Hopkins Medicine, GHD may be congenital, meaning a child is born with the condition, or acquired later in childhood because of injury, tumors, infections, radiation therapy, or other disorders affecting the pituitary gland. In many children, however, no identifiable cause is found, a condition known as idiopathic growth hormone deficiency.
Children with GHD typically grow more slowly than expected for their age and may be noticeably shorter than classmates despite having normal body proportions. Other signs can include delayed puberty, increased body fat around the waist, reduced muscle mass, younger-looking facial features, and slower bone development.
Because these symptoms can overlap with other growth disorders, physicians usually monitor a child's growth over time before ordering additional testing.
Diagnosis often begins with a review of a child's medical history and growth charts, followed by blood tests that measure growth hormone-related markers such as insulin-like growth factor 1 (IGF-1). Doctors may also perform specialized growth hormone stimulation tests, bone age X-rays, and magnetic resonance imaging (MRI) to evaluate the pituitary gland when necessary.
Treatment typically involves regular injections of synthetic human growth hormone. Therapy is generally continued until a child reaches an appropriate height or finishes growing. Research shows that children who begin treatment early often experience significant improvements in growth and adult height, particularly when therapy is carefully monitored by pediatric endocrinologists.
Treatment Is the First Step, Diligence Takes It Further
Messi's journey illustrates that a diagnosis of growth hormone deficiency does not define a child's future. While not every child with GHD will become a professional athlete, his experience highlights the importance of recognizing growth concerns early and seeking medical evaluation rather than dismissing slow growth as simply being a "late bloomer."
His story also demonstrates the value of timely treatment. Growth hormone therapy is most effective while a child's growth plates remain open, making early diagnosis an important factor in improving long-term outcomes. For parents, regular pediatric checkups and tracking a child's growth can help identify potential problems before they become more difficult to treat.
Perhaps most importantly, Messi's career serves as a reminder that medical conditions need not limit a person's potential. With appropriate diagnosis, evidence-based treatment, and ongoing medical care, many children with growth hormone deficiency are able to achieve normal growth and lead healthy, active lives.
